raw shard 375
Browse files- raw/shard_00375.jsonl +5 -0
raw/shard_00375.jsonl
ADDED
|
@@ -0,0 +1,5 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{"session_id": "atlas-8bf3d89af6", "tier": "text", "task_instruction": "Determine the cure rate for different leukemia types based on the passage.", "source": "llm_generated", "grounded_in": "wikitext-103", "steps": [{"step_index": 0, "observation": {"text": "The passage discusses cure rates in clinical trials for AML and promyelocytic leukemia.", "image_path": null, "audio_path": null}, "reasoning": "Clinical trials often have higher cure rates because they include healthier, younger participants who can tolerate aggressive treatments.", "action": {"type": "text_response", "value": "Identify the specific cure rate figures provided for each leukemia type."}, "refers_back_to": null}, {"step_index": 1, "observation": {"text": "The cure rate for AML in clinical trials is 20–45%, but this might be higher for other types.", "image_path": null, "audio_path": null}, "reasoning": "However, the overall cure rate for all AML patients, including the elderly and those who can't handle aggressive therapy, is likely lower than the clinical trial rates.", "action": {"type": "text_response", "value": "Note that the overall cure rate for AML is lower than the trial rates."}, "refers_back_to": null}, {"step_index": 2, "observation": {"text": "Promyelocytic leukemia has a much higher cure rate.", "image_path": null, "audio_path": null}, "reasoning": "The passage states that cure rates for promyelocytic leukemia can be as high as 98%.", "action": {"type": "text_response", "value": "Record the 98% cure rate for promyelocytic leukemia."}, "refers_back_to": null}, {"step_index": 3, "observation": {"text": "AML cure rates in clinical trials are 20–45%, but the overall rate is lower.", "image_path": null, "audio_path": null}, "reasoning": "Therefore, the cure rates for different leukemia types are as follows: AML has 20–45% in trials and likely lower overall, while promyelocytic leukemia has a 98% cure rate.", "action": {"type": "text_response", "value": "Summarize the cure rates for each leukemia type."}, "refers_back_to": null}], "task_complexity": "high", "language": "en", "license": "CC-BY-SA-3.0", "date_created": "2026-08-18", "_structural_pass": true, "_structural_reason": "ok", "_repaired": false, "_seed_type": "wikitext", "_seed_content": "Cure rates in clinical trials have ranged from 20 – 45 % ; although clinical trials often include only younger people and those able to tolerate aggressive therapies . The overall cure rate for all people with AML ( including the elderly and those unable to tolerate aggressive therapy ) is likely lower . Cure rates for promyelocytic leukemia can be as high as 98 % ."}
|
| 2 |
+
{"session_id": "atlas-8b72fe3cac", "tier": "text", "task_instruction": "Determine the annual number of new AML cases in the United States based on the passage.", "source": "llm_generated", "grounded_in": "wikitext-103", "steps": [{"step_index": 0, "observation": {"text": "The passage mentions there are approximately 10 to 500 new cases each year in the United States.", "image_path": null, "audio_path": null}, "reasoning": "I need to calculate the annual number of new AML cases using the provided range.", "action": {"type": "text_response", "value": "Since the passage gives a range, the exact number isn't specified, so I'll state that the annual number falls between 10 and 500 cases."}, "refers_back_to": null}, {"step_index": 1, "observation": {"text": "The incidence rate has remained stable from 1995 through 2005.", "image_path": null, "audio_path": null}, "reasoning": "This indicates that the number of cases each year hasn't fluctuated much over this period.", "action": {"type": "text_response", "value": "Therefore, the annual number of new AML cases remains consistently between 10 and 500 each year in the U.S."}, "refers_back_to": null}], "task_complexity": "low", "language": "en", "license": "CC-BY-SA-3.0", "date_created": "2026-08-18", "_structural_pass": true, "_structural_reason": "ok", "_repaired": false, "_seed_type": "wikitext", "_seed_content": "Acute myeloid leukemia is a relatively rare cancer . There are approximately 10 @,@ 500 new cases each year in the United States , and the incidence rate has remained stable from 1995 through 2005 . AML accounts for 1 @.@ 2 % of all cancer deaths in the United States ."}
|
| 3 |
+
{"session_id": "atlas-33a4e8591e", "tier": "text", "task_instruction": "Analyze the factors contributing to the incidence of AML and their demographic implications.", "source": "llm_generated", "grounded_in": "wikitext-103", "steps": [{"step_index": 0, "observation": {"text": "AML incidence rises with age, with a median diagnosis at 63 years.", "image_path": null, "audio_path": null}, "reasoning": "This shows that age is a major factor in AML development. As people age, their bodies become more prone to diseases like blood cancers, including AML.", "action": {"type": "text_response", "value": "Investigate age-related risk factors in AML."}, "refers_back_to": null}, {"step_index": 1, "observation": {"text": "AML is prevalent in adults, making up 90% of acute leukemias, while rare in children.", "image_path": null, "audio_path": null}, "reasoning": "This indicates AML mainly affects adults, especially those over 63. Children are less affected, so adult demographics are crucial for incidence studies.", "action": {"type": "text_response", "value": "Focus on adult demographics in AML incidence analysis."}, "refers_back_to": null}, {"step_index": 2, "observation": {"text": "Therapy-related AML is increasing, now 10-20% of cases.", "image_path": null, "audio_path": null}, "reasoning": "The rise in therapy-related AML points to prior chemotherapy as a significant contributing factor. This means individuals with a history of chemo are at higher risk for AML later in life.", "action": {"type": "text_response", "value": "Study the impact of prior chemotherapy on AML incidence."}, "refers_back_to": null}, {"step_index": 3, "observation": {"text": "AML is more common in men, with a male-to-female ratio of 1.3:1.", "image_path": null, "audio_path": null}, "reasoning": "This sex-based disparity suggests biological or genetic factors may make men more susceptible. Understanding these could help in targeted prevention and treatment strategies.", "action": {"type": "text_response", "value": "Explore biological and genetic factors in AML susceptibility among men."}, "refers_back_to": null}], "task_complexity": "high", "language": "en", "license": "CC-BY-SA-3.0", "date_created": "2026-08-18", "_structural_pass": true, "_structural_reason": "ok", "_repaired": false, "_seed_type": "wikitext", "_seed_content": "The incidence of AML increases with age ; the median age at diagnosis is 63 years . AML accounts for about 90 % of all acute leukemias in adults , but is rare in children . The rate of therapy @-@ related AML ( that is , AML caused by previous chemotherapy ) is rising ; therapy @-@ related disease currently accounts for about 10 – 20 % of all cases of AML . AML is slightly more common in men , with a male @-@ to @-@ female ratio of 1 @.@ 3 : 1 ."}
|
| 4 |
+
{"session_id": "atlas-29aa91dbbd", "tier": "text", "task_instruction": "Analyze the geographic variation in AML incidence and determine the possible factors contributing to it.", "source": "llm_generated", "grounded_in": "wikitext-103", "steps": [{"step_index": 0, "observation": {"text": "AML incidence varies geographically among adults and children.", "image_path": null, "audio_path": null}, "reasoning": "The passage mentions that adult AML rates are higher in North America, Europe, and Oceania, but lower in Asia and Latin America. For children, the pattern is different, with lower rates in North America and India compared to other Asian regions. This variation suggests that factors like population genetics and environmental influences might be at play.", "action": {"type": "text_response", "value": ""}, "refers_back_to": null}, {"step_index": 1, "observation": {"text": "Adult AML is more common in certain regions.", "image_path": null, "audio_path": null}, "reasoning": "North America, Europe, and Oceania have higher adult AML rates. This could be due to genetic predispositions unique to these populations or environmental factors present in these regions that contribute to AML development.", "action": {"type": "text_response", "value": ""}, "refers_back_to": null}, {"step_index": 2, "observation": {"text": "Childhood AML patterns differ from adult patterns.", "image_path": null, "audio_path": null}, "reasoning": "While adult AML is higher in North America and Europe, childhood AML is less common there compared to other parts of Asia. This inverse relationship suggests that different genetic or environmental factors influence adult and childhood AML separately.", "action": {"type": "text_response", "value": ""}, "refers_back_to": null}, {"step_index": 3, "observation": {"text": "Possible contributing factors include population genetics and environment.", "image_path": null, "audio_path": null}, "reasoning": "The passage attributes these differences to population genetics, environmental factors, or a combination of both. Therefore, to understand the variation, one must consider both genetic predispositions and environmental influences across different regions.", "action": {"type": "text_response", "value": ""}, "refers_back_to": null}], "task_complexity": "high", "language": "en", "license": "CC-BY-SA-3.0", "date_created": "2026-08-18", "_structural_pass": false, "_structural_reason": "step 0 missing 'action'", "_repaired": false, "_seed_type": "wikitext", "_seed_content": "There is some geographic variation in the incidence of AML . In adults , the highest rates are seen in North America , Europe , and Oceania , while adult AML is rarer in Asia and Latin America . In contrast , childhood AML is less common in North America and India than in other parts of Asia . These differences may be due to population genetics , environmental factors , or a combination of the two ."}
|
| 5 |
+
{"session_id": "atlas-705efe01bf", "tier": "text", "task_instruction": "Identify the key observations and terms related to the early descriptions of leukemia in the passage.", "source": "llm_generated", "grounded_in": "wikitext-103", "steps": [{"step_index": 0, "observation": {"text": "The passage mentions that Alfred Armand Louis Marie Velpeau described a case of leukemia in 1827.", "image_path": null, "audio_path": null}, "reasoning": "This suggests that Velpeau was one of the first to document leukemia, noting symptoms like fever and changes in blood consistency.", "action": {"type": "text_response", "value": "Identify Velpeau as the first to describe leukemia with specific symptoms."}, "refers_back_to": null}, {"step_index": 1, "observation": {"text": "Velpeau noted the blood had a consistency like gruel and attributed it to white corpuscles.", "image_path": null, "audio_path": null}, "reasoning": "This indicates he observed a connection between blood changes and an overabundance of white blood cells, a hallmark of leukemia.", "action": {"type": "text_response", "value": "Recognize Velpeau's observation of blood abnormalities linked to white corpuscles."}, "refers_back_to": null}, {"step_index": 2, "observation": {"text": "In 1845, J.H. Bennett reported cases with enlarged spleens and blood changes, using the term 'leucocythemia'.", "image_path": null, "audio_path": null}, "reasoning": "This shows that by the mid-19th century, the condition was being recognized and named, though terminology may have evolved.", "action": {"type": "text_response", "value": "Identify Bennett's contribution to the understanding and naming of leukemia."}, "refers_back_to": null}], "task_complexity": "low", "language": "en", "license": "CC-BY-SA-3.0", "date_created": "2026-08-18", "_structural_pass": true, "_structural_reason": "ok", "_repaired": false, "_seed_type": "wikitext", "_seed_content": "The first published description of a case of leukemia in medical literature dates to 1827 , when French physician Alfred @-@ Armand @-@ Louis @-@ Marie Velpeau described a 63 @-@ year @-@ old florist who developed an illness characterized by fever , weakness , urinary stones , and substantial enlargement of the liver and spleen . Velpeau noted the blood of this person had a consistency \" like gruel \" , and speculated the appearance of the blood was due to white corpuscles . In 1845 , a series of people who died with enlarged spleens and changes in the \" colors and consistencies of their blood \" was reported by the Edinburgh @-@ based pathologist J.H. Bennett ; he used the term \" leucocythemia \" to describe this pathological condition ."}
|